The 2 most recent market catalysts affecting $CERN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 4, 2026
Corporate Catalyst
Bullish
Impact 65
Cerenome Subsidiary CNSide Diagnostics Enters National In-Network Agreement with Aetna
Cerenome's subsidiary, CNSide Diagnostics, announced a national in-network agreement with Aetna for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration test. This is signi…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 75
Cerenome Announces In-Network Provider Agreement With Health Care Service Corporation For CNSide CSF Assay, Effective August 1; Total Contracted Coverage Reaches About 153 Million
Cerenome's new in-network agreement with Health Care Service Corporation is a significant positive catalyst, expanding coverage for its CNSide CSF Assay to approximately 153 millio…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.